Drug manufacturers will pay a new excise tax on certain sales

The US Treasury Department has proposed new rules for an excise tax on specific drug sales. This means drug manufacturers, producers, and importers will have to calculate and pay this tax on designated drugs sold during certain periods.

This proposed tax will directly affect the revenue streams of pharmaceutical companies. It adds a new cost to selling certain drugs, which could influence pricing strategies or research and development investments. The tax aims to recover some costs related to drug pricing, shifting a financial burden directly onto manufacturers.